Preclinical trials from a top pre-clinical Contract Research Organization in Kiev, UA.
We are an independent CRO based in the U.S. that conducts preclinical drug testing in top-notch, Good Laboratory Practices certified research facilities in Kiev, UA. Our testing sites are sponsored by the UNAMS and Ministry of Health and offer support for commercial development of new medicine discoveries as part of their core purpose. The CRO was created to provide the high quality, inexpensive services of these laboratories to new bio-tech companies in the USA and EU, thereby providing them with an attractive option for advancing development programs rapidly and at much lower cost than other commercial Contract Research Organizations. We offer a broad range of preclinical research including drug safety, acute and chronic toxicity, pharma screening, bio-availability , bioequivalence, and extensive in vivo and in vitro screening for anticancer activity.
Our pre-clinical CRO is able to price pre-clinical research far below other Contract Research Organizations since we maintain a very low overhead in the U.S. and perform all research in Ukraine where labor and laboratory costs are much lower. Our team in the United States consists only of the organization principals who deal directly with clients; we don’t have any marketing costs other than our web site, and no central offices, supporting staff or other overhead to inflate prices. We have much lower research conduct costs in Ukraine due to much lower workers rates and are able to offer our most attractive pricing for long-term and more complex preclinical studies where labor is the most significant portion of the overall price. Because we use the same reliable international providers for lab animals, reagents and laboratory supplies as other Contract Research Organizations, we don’t have any cost savings on these materials and thus less overall cost savings for very short-term preclinical tests. But, regardless of your test protocol and length, our goal is to give our customers the greatest possible value for their investment.